Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

Share Price is delayed by 15 minutes
Get Live Data
445.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.50 (0.112%)
Market Cap: £658.17m
CRE Live PriceLast checked at - London Stock Exchange

Intraday Conduit Hldg Share Chart

Interim Management Statement

7 Aug 2008 07:00

RNS Number : 8005A
Creston PLC
07 August 2008
 



Press Release  7 August 2008

Creston plc 

Interim Management Statement 

Creston plc (LSE: CRE), the Insight and Communications Group, announces its interim management statement for the period 1 April 2008 to 6 August 2008.

Operational Trading

The Group has started the year with a like-for-like revenue growth of 5% during the first quarter April to June 2008. It is also benefiting from strong new business wins  from major clients including: COI, Daily Mirror, House of Fraser, Insignia (General Motors) and The Health Lottery in its consumer communication agency DLKW; new product wins from GSK and Pfizer in its healthcare communication agency PAN; and Berry Bros, Gordons Gin, Lipton, PG Tips, Pfizer and Sainsbury's Business Direct in its direct marketing agency TMW. Other new business wins across the Group include McNeil, Miller & Pilsner (SAB), Takeda and Trainline and the Board is pleased with the retention of the Halifax advertising account by DLKW.

The Group has continued to develop strategically across the four pillars of growth outlined in the Company's preliminary announcement for the year ended March 2008. The progress includes:

the continued consolidation in the Insight Division with the integration of MSTS to MSL;

developing the integrated and digital client offer to benefit from the continued shift of spend from traditional advertising to integrated on and off line communication;

driving synergies across the Group companies with the new offer of healthcare relationship marketing from the joint venture "Hi" between PAN and TMW. 

geographic expansion to broaden our client offer with a minority ownership in a new start up in Asia under the brand name of the subsidiary TRA.

 

Ware encouraged by the continued growth in revenue, whilst we remain focussed on controlling our costs and maximising efficiencies in order to respond quickly to changes in the market conditions.

Having renegotiated our banking facility, we settled in April 2008 the remaining DLKW earn out liability of £13.9 million in cash (£1 million) and loan notes (£12.9 million) with a nine month redemption. The Group maintains significant headroom in all its banking covenants giving the Group the option to settle all future earn out liabilities in loan notes and cash rather than equity should it be appropriate.

Outlook

The diversified nature of the Group, with a heavy weighting in market research and direct marketing, is proving a resilient model as demonstrated by the first quarter revenue growth achieved in a volatile economic climate. Based on this progress to date, the Group remains on course to meet the Board's expectations for the full year.

For further information, please contact:

Creston plc

020 7930 9757

Don Elgie, Chief Executive

Barrie Brien, COO/CFO

www.creston.com 

Hogarth Partnership Limited

020 7357 9477

Chris Matthews/Sarah Macleod

 

About Creston plc
 
§ Creston is an Insight and Communications marketing services group. The Board’s aim is to identify synergistic benefits between its marketing services companies offering premium services such as market research, direct and interactive marketing, advertising, public relations, insight and to build a Group that offers clients solutions to both existing and future marketing needs across both on-line and off-line channels.
 
§ Creston’s companies boast a range of blue-chip clients including the Amazon, AstraZeneca, Bayer, BMW, BT, Burger King, Capital One, Canon, COI Communications, Cow & Gate, Daily Mirror, Diageo, eBay, First Direct, General Motors, GlaxoSmithKline, Halifax, Homeform, House of Fraser, Kimberly-Clark, Lexus, Lloyds Black Horse, Morrisons, NHS Lottery, Nissan, Norwich Union, Pfizer, Roche Diagnostics, Royal Mail, SAB Miller, Sainsbury’s, Tesco, Thorpe Park, Toshiba, Trinity Mirror, T-Mobile, Tropicana, Unilever, Vodafone, Walkers and WH Smith.
 
§ Creston’s share price is quoted in the Financial Times, The Daily Telegraph, The Times and the London Evening Standard.
 
 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEASPKEELPEFE
Date   Source Headline
16th May 20254:48 pmRNSDirector/PDMR Shareholding
14th May 20255:57 pmRNSResult of AGM
14th May 20255:51 pmRNSDirector/PDMR Shareholding
14th May 20257:00 amRNSCEO appointment and Directorate Changes
14th May 20257:00 amRNSTrading Update for Q1 2025
6th May 20257:00 amRNSNotice of Q1 2025 Trading Update
22nd Apr 20257:00 amRNSAppointment of Interim CUO
10th Apr 20255:07 pmRNSNotice of AGM
10th Apr 20254:40 pmRNSHolding(s) in Company
10th Apr 20254:39 pmRNSPurchase of Shares by Employee Benefit Trust
9th Apr 20255:49 pmRNSDirector/PDMR Shareholding
9th Apr 20255:33 pmRNSPurchase of Shares by Employee Benefit Trust
8th Apr 20252:59 pmRNSPurchase of Shares by Employee Benefit Trust
7th Apr 20251:28 pmRNSPurchase of Shares by Employee Benefit Trust
4th Apr 20255:27 pmRNSPurchase of Shares by Employee Benefit Trust
4th Apr 20251:21 pmRNSDirector/PDMR Shareholding
3rd Apr 20253:22 pmRNSDirector/PDMR Shareholding
3rd Apr 20253:08 pmRNSPurchase of Shares by Employee Benefit Trust
2nd Apr 20255:10 pmRNSHolding(s) in Company
2nd Apr 20255:09 pmRNSPurchase of Shares by Employee Benefit Trust
1st Apr 20256:20 pmRNSDirector/PDMR Shareholding
31st Mar 20257:00 amRNSCEO Retirement
26th Mar 20255:54 pmRNSDirector/PDMR Shareholding
26th Mar 20255:51 pmRNSDirector/PDMR Shareholding
26th Mar 20255:50 pmRNSDirector/PDMR Shareholding
26th Mar 20255:50 pmRNSDirector/PDMR Shareholding
26th Mar 20255:45 pmRNSDirector/PDMR Shareholding
26th Mar 20255:44 pmRNSDirector/PDMR Shareholding
26th Mar 20255:43 pmRNSDirector/PDMR Shareholding
26th Mar 20255:43 pmRNSDirector/PDMR Shareholding
14th Mar 202512:20 pmRNSNotification of Major Holdings
14th Mar 202512:19 pmRNSNotification of Major Holdings
11th Mar 202512:22 pmRNSNotification of Major Holdings
27th Feb 20258:00 amRNSPublication of 2024 Annual Report and Accounts
25th Feb 20257:00 amRNSDirector/PDMR Shareholding
24th Feb 20257:00 amRNSDirector/PDMR Shareholding
19th Feb 20257:00 amRNSPreliminary results for the year ended 31/12/24
30th Jan 20257:00 amRNSNotice of Results
18th Dec 20247:00 amRNSComment on AM Best ratings outlook
15th Nov 20247:00 amRNSDirector/PDMR Shareholding
13th Nov 20245:35 pmRNSDirector/PDMR Shareholding
8th Nov 20245:16 pmRNSDirector/PDMR Shareholding
8th Nov 20245:16 pmRNSDirector/PDMR Shareholding
8th Nov 20247:00 amRNSDirector/PDMR Shareholding - Amendment
7th Nov 20244:26 pmRNSDirector/PDMR Shareholding
6th Nov 20247:00 amRNSTrading Statement
23rd Oct 20243:02 pmRNSNotice of Results
4th Sep 20243:36 pmRNSDirector/PDMR Shareholding
14th Aug 20247:00 amRNSDirector/PDMR Shareholding
31st Jul 20247:00 amRNSInterim Results for the six months to 30/06/2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.